SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

362.1708669

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

36.4

41405.8

EPS(TTM)

Face Value()

Div & Yield %

91.04

0.85

Back

Ajanta Pharma consolidated net profit rises 49.18% in the September 2026 quarter

Oct 30,2026

Net profit of Ajanta Pharma rose 49.18% to Rs 388.14 crore in the quarter ended September 2026 as against Rs 260.19 crore during the previous quarter ended September 2025. Sales rose 32.53% to Rs 1794.16 crore in the quarter ended September 2026 as against Rs 1353.73 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1794.16	1353.73	33
OPM %	30.52	24.22	-
PBDT	582.71	383.78	52
PBT	535.15	340.81	57
NP	388.14	260.19	49

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)